Diabetes, Metabolic Syndrome and Obesity
Volume 15, 2022 - Issue
ORIGINAL RESEARCH
Efficacy of Dapagliflozin in Southern Europe Across the Spectrum of Characteristics of Type 2 Diabetes: An International Real-World Analysis
Gian Paolo Fadini1 Division of Metabolic Diseases, Department of Medicine, University of Padova, Padua, ItalyCorrespondence[email protected]
https://orcid.org/0000-0002-6510-2097View further author information
https://orcid.org/0000-0002-6510-2097View further author information, , , Beatriz González2 Hospital Virgen Macarena (Sevilla); Hospital Vithas (Sevilla), Sevilla, Spainhttps://orcid.org/0000-0001-8881-4233View further author information
https://orcid.org/0000-0001-8881-4233View further author information, Nikolaos Tentolouris3 Diabetes Centre, First Department of Propaedeutic Internal Medicine, Medical School, National and Kapodistrian University of Athens, Laiko General Hospital, Athens, Greecehttps://orcid.org/0000-0003-0615-2534View further author information
https://orcid.org/0000-0003-0615-2534View further author information & 